Distal proctocolitis and n-3 polyunsaturated fatty acids (n-3 PUFAs): the mucosal effect in situ
- PMID: 10798610
- DOI: 10.1023/a:1006698728816
Distal proctocolitis and n-3 polyunsaturated fatty acids (n-3 PUFAs): the mucosal effect in situ
Abstract
It has been postulated that patients with ulcerative colitis (UC) have altered reactivity of gut-associated lymphoid tissue. In such cases there is intense infiltration of the mucosa with immune competent cells and associated tissue damage. We have shown previously that the dietary supplementation with the n-3 polyunsaturated fatty acids (n-3 PUFAs), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) results in significant systemic immune suppression. The aim of this study, therefore, was to evaluate the in situ effect of n-3 PUFAs on distal proctocolitis. Each patient received either fish oil extract (EPA 3.2 g, DHA 2.4 g) (n = 9) or sunflower oil (n = 9) daily in a double blind manner for six months. Monthly assessment included: (1) disease activity using clinical, sigmoidoscopic, and histological scores and (2) immunohistochemical analysis (immunoglobulins, CD profiles) of rectal biopsy specimens (before and after six months supplementation) using monoclonal antibodies and quantitative computer-assisted video image analysis. Prior to receiving supplementation, patients with proctocolitis (n = 18) showed significantly higher numbers of cells expressing CD3 (pan T cells) and HLA-DR and IgM containing cells compared with non-colitic controls (n = 8). Six months supplementation with n-3 PUFAs resulted in significant reduction in the number of cells expressing CD3 and HLA and the percentage of cells containing IgM. There was no significant change in the CD20 nor the percentage of IgG or IgA containing cells in either group of patients with procto-colitis. In patients receiving n-3 PUFA supplementation, there was improvement in the disease activity and histological scores, compared with pretreatment evaluation. This study has demonstrated both evidence of suppression of in situ immune reactivity and concurrent reduction in disease activity in patients with proctocolitis receiving n-3 PUFA supplementation. This may have important implication for therapy in patients with ulcerative colitis.
Similar articles
-
Distal procto-colitis and n-3 polyunsaturated fatty acids: the mechanism(s) of natural cytotoxicity inhibition.Eur J Clin Invest. 2000 Jan;30(1):58-65. doi: 10.1046/j.1365-2362.2000.00581.x. Eur J Clin Invest. 2000. PMID: 10620003 Clinical Trial.
-
Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y.Am J Clin Nutr. 2001 Mar;73(3):539-48. doi: 10.1093/ajcn/73.3.539. Am J Clin Nutr. 2001. PMID: 11237929 Clinical Trial.
-
Distal procto-colitis, natural cytotoxicity, and essential fatty acids.Am J Gastroenterol. 1998 May;93(5):804-9. doi: 10.1111/j.1572-0241.1998.229_a.x. Am J Gastroenterol. 1998. PMID: 9625132 Clinical Trial.
-
Marine polyunsaturated fatty acids and cancer therapy.Br J Cancer. 2013 Feb 19;108(3):486-92. doi: 10.1038/bjc.2012.586. Epub 2013 Jan 8. Br J Cancer. 2013. PMID: 23299528 Free PMC article. Review.
-
Fortification of foods with omega-3 polyunsaturated fatty acids.Crit Rev Food Sci Nutr. 2014;54(1):98-114. doi: 10.1080/10408398.2011.578221. Crit Rev Food Sci Nutr. 2014. PMID: 24188235 Review.
Cited by
-
Omega-3 fatty acids in the maintenance of ulcerative colitis.JRSM Short Rep. 2010 Jun 30;1(1):15. doi: 10.1258/shorts.2010.010004. JRSM Short Rep. 2010. PMID: 21103107 Free PMC article. No abstract available.
-
Antioxidant Supplements and Gastrointestinal Diseases: A Critical Appraisal.Med Princ Pract. 2017;26(3):201-217. doi: 10.1159/000468988. Epub 2017 Mar 8. Med Princ Pract. 2017. PMID: 28278495 Free PMC article.
-
Actors and Factors in the Resolution of Intestinal Inflammation: Lipid Mediators As a New Approach to Therapy in Inflammatory Bowel Diseases.Front Immunol. 2017 Oct 23;8:1331. doi: 10.3389/fimmu.2017.01331. eCollection 2017. Front Immunol. 2017. PMID: 29109724 Free PMC article. Review.
-
Randomized clinical trial of the effects of perioperative use of immune-enhancing enteral formula on metabolic and immunological status in patients undergoing esophagectomy.World J Surg. 2007 Nov;31(11):2150-7; discussion 2158-9. doi: 10.1007/s00268-007-9170-8. World J Surg. 2007. PMID: 17653789 Clinical Trial.
-
The fatty acid profile of the erythrocyte membrane in initial-onset inflammatory bowel disease patients.Dig Dis Sci. 2013 May;58(5):1235-43. doi: 10.1007/s10620-012-2508-6. Epub 2013 Jan 11. Dig Dis Sci. 2013. PMID: 23306839
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous